Vanguard Group Inc Heska Corp Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$62.17 - $97.62 $154,243 - $242,195	-2,481 Reduced 0.34%	730,939 $71.4 Million
Q4 2022 Feb 10, 2023	BUY	$60.21 - $77.74 $1.45 Million - $1.87 Million	24,033 Added 3.39%	733,420 $45.6 Million
Q3 2022 Nov 14, 2022	SELL	$72.92 - $99.73 $181,352 - $248,028	-2,487 Reduced 0.35%	709,387 $51.7 Million
Q2 2022 Aug 12, 2022	BUY	$84.23 - $147.57 $319,737 - $560,175	3,796 Added 0.54%	711,874 $67.3 Million
Q1 2022 May 13, 2022	BUY	$122.89 - $171.74 $2.61 Million - $3.64 Million	21,203 Added 3.09%	708,078 $97.9 Million
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $2.45 Million - $4.18 Million	15,714 Added 2.34%	686,875 $125 Million
Q3 2021 Nov 12, 2021	BUY	$228.69 - $274.2 $4.64 Million - $5.57 Million	20,301 Added 3.12%	671,161 $174 Million
Q2 2021 Aug 13, 2021	BUY	$169.89 - $231.37 $111 Million - $151 Million	650,860 New	650,860 $150 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.